Dokter Els Luypaert - fysische geneeskunde en revalidatie
0831.116.685 · rovalta.com · 28/09/2026
Dokter Els Luypaert - fysische geneeskunde en revalidatie
Financial year 2025 · Closed on 31/03/2025
Overview
Identity
Source · BCE/KBODokter Els Luypaert - fysische geneeskunde en revalidatie is a Private limited company incorporated in 2010. Its main activity is: Specialist medical practice activities. Its registered office is in Lievegem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0831.116.685
- Incorporation
- 16/11/2010
- Legal form
- Private limited company
- Registered office
- Bauwerwaan 42
9930 Lievegem · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/03/2025
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 254,5 k € | -24.6% | 337,6 k € | +27.3% | 265,2 k € | -14.3% | 309,5 k € | +21.1% | 255,5 k € |
| EBITDA | 252,2 k € | -24.5% | 334,2 k € | +27.6% | 261,9 k € | -14.7% | 307 k € | +21.3% | 253,1 k € |
| Operating result | 238,2 k € | -25.6% | 320,2 k € | +28.8% | 248,5 k € | -15.2% | 293,2 k € | +26.9% | 231,1 k € |
| Net result | 168,9 k € | -22.8% | 218,9 k € | +27.5% | 171,6 k € | -15.2% | 202,3 k € | +26.4% | 160,1 k € |
| Balance sheet | |||||||||
| Equity | 1,4 M € | +6.3% | 1,3 M € | +12.9% | 1,1 M € | +8.6% | 1 M € | -1.0% | 1,1 M € |
| Total assets | 1,6 M € | +10.2% | 1,4 M € | +15.9% | 1,2 M € | +10.8% | 1,1 M € | -0.6% | 1,1 M € |
| Cash | 1,1 M € | +54.3% | 719,7 k € | -22.2% | 925,3 k € | +26.1% | 733,6 k € | -8.8% | 804,5 k € |
| Debts | 192,2 k € | +49.0% | 129 k € | +57.5% | 81,9 k € | +53.3% | 53,5 k € | +7.3% | 49,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/03/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Els Luypaert | Managersince 10/11/2010 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/10/2025 | 27/10/2024 | 31/10/2023 | 03/11/2022 | 29/10/2021 | 30/10/2020 |
| General meeting | 26/09/2025 | 27/09/2024 | 29/09/2023 | 30/09/2022 | 24/09/2021 | 25/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/03/2025 | 26/09/2025 | 24/10/2025 | Dutch | |
| Micro model | 31/03/2024 | 27/09/2024 | 27/10/2024 | Dutch | |
| Micro model | 31/03/2023 | 29/09/2023 | 31/10/2023 | Dutch | |
| Micro model | 31/03/2022 | 30/09/2022 | 03/11/2022 | Dutch | |
| Micro model | 31/03/2021 | 24/09/2021 | 29/10/2021 | Dutch | |
| Micro model | 31/03/2020 | 25/09/2020 | 30/10/2020 | Dutch | |
| Micro model | 31/03/2019 | 27/09/2019 | 22/10/2019 | Dutch | |
| Micro model | 31/03/2018 | 28/09/2018 | 01/10/2018 | Dutch | |
| Micro model | 31/03/2017 | 29/09/2017 | 30/10/2017 | Dutch | |
| Abridged model | 31/03/2016 | 30/09/2016 | 30/09/2016 | Dutch | |
| Abridged model | 31/03/2015 | 25/09/2015 | 26/10/2015 | Dutch | |
| Abridged model | 31/03/2014 | 26/09/2014 | 29/10/2014 | Dutch | |
| Abridged model | 31/03/2013 | 27/09/2013 | 30/10/2013 | Dutch | |
| Abridged model | 31/03/2012 | 28/09/2012 | 19/11/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Els Luypaert | Managersince 10/11/2010 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Bauwerwaan 42, 9930 LievegemCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00549052 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter Els Luypaert - fysische geneeskunde en revalidatieCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00549052 |
Events
- 2025Annual accounts 2025168,9 k €↓
- 2024Annual accounts 2024218,9 k €↑
- 2023Annual accounts 2023171,6 k €↓
- 2022Annual accounts 2022202,3 k €↑
- 2021Annual accounts 2021160,1 k €↑
- 2020Annual accounts 2020137,7 k €↑
- 2019Annual accounts 201988,7 k €↑
- 2018Annual accounts 201872,5 k €↓
- 2017Annual accounts 201781,8 k €↓
- 2016Annual accounts 2016115,8 k €↓
- 2015Annual accounts 2015127,9 k €↑
- 2014Annual accounts 2014111,5 k €↓
- 2013Annual accounts 2013126,2 k €↑
- 2012Annual accounts 201219,9 k €
- 16/11/2010IncorporationPrivate limited company